Clinical Trial Update: Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan and cetuximab with or without bevacizumab in RAS wild-type locally advanced or metastatic colorectal cancer unsuitable for s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Colorectal Adenocarcinoma, RAS Wild Type | Phase 2 | Status: COMPLETED | Results posted: 2020-02-28